FNY Partners Fund’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

FNY Partners Fund’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,200	Closed	-$527K	–	663
2017 Q3	$527K	Sell	5,200 -500	-9%	-$53.5K	0.09%	101
2017 Q2	$571K	Buy	5,700 +1,800	+46%	+$194K	0.14%	64
2017 Q1	$471K	Buy	3,900 +2,100	+117%	+$258K	0.05%	176
2016 Q4	$201K	Buy	+1,800	New	+$217K	0.01%	154

Other funds holding GWPH

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

FNY Partners Fund's GWPH Position: Q4 2017 in Review

FNY Partners Fund sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2017, closing a stake of 5,200 shares — an estimated $527K sold.

FNY Partners Fund first reported a position in GWPH in Q4 2016 and held it in 4 quarters. The position peaked at $571K in Q2 2017. 204 funds tracked by Wall St. Rank hold GWPH as of Q4 2017.

FNY Partners Fund reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
FNY Partners Fund sold 5,200 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2017, an estimated $527K.
FNY Partners Fund first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 4 quarters.
FNY Partners Fund's GW Pharmaceuticals Plc American Depositary Shares position peaked at $571K in Q2 2017.
204 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2017.

Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.